Nina Rognon

ImCheck Therapeutics once again recognized for its potential to become an international leader in healthcare innovation   🏆 ImCheck is a winner of the French Tech 120 program for the 5th year in a row and a winner of the new French Tech 2030 program announced nearly a year ago. 👩‍⚕️ ImCheck is one of the few therapeutics-focused biotech and healthcare start-up/scale-up companies selected as one of the 120 companies for the fifth edition of the French Tech Next40/120 program and as one of the 125 recipients of the first edition of the French Tech 2030 program. 💪 The awards highlight ImCheck as one of the leaders among the companies supporting the ambitions of the Innovation Santé 2030 plan.   ImCheck Therapeutics announced today that it is part of the prestigious French Tech 120 for the fifth year in a row. Being once again a #FT120 winner and one of the 125 companies selected for the #FrenchTech2030 underscores ImCheck's potential to become a world-class leader in immunotherapy. ImCheck benefits from these two programs of excellence launched by the French government, serving one of the 6 priorities of France 2030: positioning France as a sovereign European leader in healthcare innovation.   "Anchored in our regional healthcare ecosystem in Marseille and backed by a syndicate of prestigious international investors, we are delighted to once again have the support and recognition of the French government and its agencies, and intend to actively contribute to France's sovereignty in healthcare innovation. We are more determined than ever to become a champion in immunotherapy on a global scale," said Pierre d'Epenoux, CEO of ImCheck Therapeutics.   We would like to thank Clara Chappaz Lise ALTER Marina Ferrari Bruno Le Maire Gabriel Attal and Emmanuel Macron for their support. #France2030 #FT120 #FrenchTech #FrenchTech2030 #HealthInnovationAgency #Innovation #Cancer

191

18 commentaires

The replay of our last edition at Doctolib is here ! We talked about to talk about “Organizing data teams for AI success” in collaboration with Doctolib. ********* Program ********* 1️⃣ How can data teams serve a bold AI vision? Anouk Barnoud, Senior Data Scientist Doctolib Diana Carrondo, Data Governance Lead Doctolib Lucille FARGEAU, Senior Analytics Engineer Doctolib 💥 Let’s deep dive into Doctolib's vision of how Artificial Intelligence can reinforce our positive impact on the millions of patients and healthcare professionals we serve in Europe. This is actually the story of how much we care about our data value chain, facing challenges and learnings like in any adventure. 2️⃣ Malt's journey in building an Internal Generative AI product for Efficiency Anaïs Ghelfi, Head of Data Platform Malt 💥 Discover how Malt designed and implemented an internal Generative AI product to enhance the team’s efficiency. Anaïs will discuss the project's journey from initial concept to final implementation, including the organizational structure, onboarding, adoption challenges, and technical hurdles faced along the way. 3️⃣ Strengthen Your Core: How a Robust Core Data Product Foundation Fuels Analytics and AI Capabilities Gaëlle SERET, Group Product Manager & Staff, Core Data Product team Decathlon Digital Enjoy !

43

2 commentaires

🚀 The highlight of the Première ligne en santé/First Line in Health was the insights from the panel discussion on modernizing healthcare systems through digital tools and data interoperability! We heard from the following thought leaders: 🙌 Gurpreet (G.P.) Singh, VP of Interoperability at ELLKAY 🙌 Emmanuelle Lamoureux, Director General, Health Care Strategies at Health Canada | Santé Canada 🙌 Abhinav Kalra, Executive Vice President at Canada Health Infoway 🙌 David O'Toole, President & CEO at Canadian Institute for Health Information (CIHI) ✨ ✨ ✨ ✨ ✨ ✨ ✨ 🤳 Check out the video ✨ ✨ ✨ ✨ ✨ ✨ ✨ ✨ Here's a summary of key points: 👏 Collaboration is Key: The panel emphasized the importance of collaboration among various stakeholders, including government bodies, healthcare providers, and private sector partners, to drive the adoption of common standards and interoperable systems. 🤩 Benefits of Data Sharing: Instead of focusing solely on the risks, there's a need to recognize the vast opportunities that come with sharing health data. By breaking down silos and sharing information, we can improve patient care, enhance efficiency, and drive innovation in healthcare delivery. 🎯 Standardization Challenges: While the need for standards like #SNOMEDCT and #HL7 #FHIR is evident, the implementation process poses challenges. These include variations in how standards are interpreted and implemented across different regions and healthcare organizations. 🚦 Role of Legislation: There's a growing consensus that legislation could play a crucial role in mandating the adoption of common standards and accelerating progress toward interoperability. This would require a coordinated effort from federal and provincial/territorial governments, as well as input from industry stakeholders. 👉 Empowering Clinicians with AI: With the influx of data, especially through AI tools, there's a need to empower clinicians to efficiently access and utilize patient information during consultations. AI-driven solutions like patient summaries can provide comprehensive overviews, helping clinicians make informed decisions in shorter time frames. 💫 Data Transformation and Mapping: While achieving consensus on standards is essential, there's also a need for data transformation and mapping mechanisms to ensure seamless interoperability across different systems and standards. ⭐ Health Data Infrastructure as Utility: Viewing health data infrastructure as a critical utility akin to transportation or power systems underscores its importance. This perspective can drive collective efforts toward building robust and interoperable healthcare systems for the benefit of all Canadians. Bobby Gheorghiu Mireille Luc, Ph.D. Justin Saindon HIMSS Eastern Canada Chapter (HIMSS Section de l’Est du Canada) Ana Maria Palusci RN, PMP, MBA- Business Analytics, Applied AI/ML #HealthTech #DigitalHealth #Interoperability #HealthcareInnovation https://lnkd.in/egcCVwD9

29

1 commentaire

As part of our role in the new France Biotech task force dedicated to the #CSR transition and transformation of the health industry, our co-founder Guillaume Richard de Vesvrotte led a webinar to take a step back on where we are at today when it comes to the sustainable transformation challenge for companies. He went over a clear update on: - new climate risks (or should we say newly covered): with #carbon reaching a certain level of maturity within companies, risk such as #biodiversity and water are becoming more and more urgent to take into consideration - new regulations: paving the way forward for companies in a accelerating manner, with a focus on #CSRD and #CSDDD - new business challenges: as ultimately this is a matter of business survival, in a world where investors, clients, consumers and overall all key stakeholders of companies will take into consideration the advancement on the ecological transformation of businesses Guillaume went also over some of our methodologies and tools to support companies in their transition. Do not hesitate to watch the replay of the webinar here: https://lnkd.in/eEfSAsSw

14

4 commentaires